Back

Coexistence of sarcopenia and osteoporosis in patients with heart failure: prevalence and association with functional status

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: The comorbid complexity of heart failure Comorbidities ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Mr Ryo Numazawa

Sapporo Medical University School of Medicine, Sapporo (Japan)

5 More presentations in this session

Presentation thumbnail
Impact of type 2 diabetes on the incidence of cardiorenal syndromes and on subsequent clinical outcomes: a propensity-matched nationwide analysis.
Professor L. Fauchier (Tours, FR)
Abstract Slides Video
Presentation thumbnail
Impact of prediabetes and type 2 diabetes mellitus on cardiac function in the general population
Doctor V. Schmitt (Mainz, DE)
Abstract Slides Video
Presentation thumbnail
Prediction of mortality and mode of death in heart failure using multimorbidity and clinical risk score systems: a nationwide analysis
Professor L. Fauchier (Tours, FR)
Abstract Slides Video
Presentation thumbnail
Loss of social role awareness, a subdomain of social frailty, is an independent predictor of future adverse events in hospitalized older patients with heart failure
Mr S. Katano (Sapporo, JP)
Abstract Slides Video
Presentation thumbnail
Verification of the impact of the improvement and worsening of anemia after discharge of heart failure on cardiorenal nutrition and the prognosis of HFpEF from the PURSUIT-HFpEF registry
Doctor T. KITAO (Osaka, JP)
Abstract Slides Video

Access the full session

Session thumbnail
The comorbid complexity of heart failure

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Presentation
The association between sarcopenia and post-discharge outcomes in patients with heart failure: data from the SMILE HF registry
thumbnail
Congress Presentation
Prognostic value of sarcopenia defined by the Sarcopenia Definitions and Outcomes Consortium criteria in patients with heart failure
thumbnail
Congress Presentation
Prognostic role of sarcopenia and effect of SGLT2-inhibitors on MACE in heart failure patients

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources